The Myc proteins are thought to play a central role in the regulation of cell proliferation and differentiation (30) . Although the biochemical function of c-Myc is uncertain, its structural similarity to other proteins of known function and its ability to bind sequence-specific DNA suggest that it is a transcription factor (5-7, 41, 42) . High expression of c-Myc can stimulate transcription from transfected plasmids and cellular genes (12, 24, 28) . It is not known whether c-Myc specifically binds to and activates these genes directly. Nevertheless, c-Myc has two hallmark characteristics of a transcriptional activator (35) : a domain that allows for binding to sequence-specific DNA (5, 41) and one that functions in transcriptional activation (26, 27) . These properties make it likely that c-Myc functions as a transcriptional activator in vivo, although the direct cellular targets of c-Myc are unknown.
High expression of Myc can also suppress the expression of specific genes (3, 17, 21, 24, 29, 30, 39, 49, 51) . Such genes include c-myc itself (17, 38, 39) , the major histocompatibility complex class I antigen gene (3), LFA-1 adhesion receptor genes (21) , and several collagen genes (51) . Although the mechanism(s) by which Myc suppresses the expression of these genes is poorly understood, it involves reduced transcription rates. A study of the factors that regulate the transcription of such genes could provide insight into this mechanism.
It is well established that overexpression of oncogenes in cells has pleiotropic effects. As hypothesized by Bishop (4) , the pleiotropic effect of oncogenes that code for transcription factors could be achieved in at least two ways. For example, transcription factors (such as c-Myc) may directly control a wide variety of genes. Alternatively, they may * Corresponding author.
control the expression or activity of other transcription factors. The latter possibility is appealing because it provides a means for amplifying the effect of a single transcription factor that has few direct cellular targets. Interestingly, several of the genes that are suppressed in cells overexpressing Myc have common transcriptional regulatory elements, raising the possibility that this effect of Myc may be mediated through a common transcription factor. We investigate this possibility here. We show that overexpression of Myc in 3T3-L1 cells alters CCAAT transcription factor/nuclear factor 1 (CTF/NF-1) and suppresses the activity of CTF/NF-1-dependent promoters in vivo.
MATERIALS AND METHODS
Plasmids and recombinant DNA techniques. pAZ1003 (44) contains 2 kb of the mouse pro-a2(I) collagen promoter and was provided by B. de Crombrugghe. A mutant of pAZ1003 (pAZ1003/NF-lm) that does not bind CTF/NF-1 was generated by site-directed mutagenesis. This mutant plasmid contains a 3-bp substitution mutation (TIIAAAGGGC GAGA) in the collagen CTF/NF-1 binding site and has been previously described (44) . pLK454 (18) contains 3 kb of the human ,-actin promoter and was provided by L. Kedes. pMSGcat contains the mouse mammary tumor virus (MMTV) promoter and was purchased from Pharmacia.
pmgAS-6 (1) contains 150 bp of the human argininosuccinate synthetase promoter. pMoCAT (48) , which contains 384 bp of the Moloney murine leukemia virus (MoMuLV) promoter, and a mutant of pMoCAT [pMo(NFlab)CAT] that lacks all four CTF/NF-1 binding sites were obtained from N. Speck. Cell culture and DNA transfections. All cell lines were grown as previously described (13) (14) (15) . Cells were made quiescent by maintaining cell monolayers at confluence for 3 days without a change of medium. Actively growing cell cultures were obtained by seeding cells at low density and allowing cultures to expand to a density 50% of that at confluence. Plasmid DNA transfections were performed as previously described (15) , using 50 ,ug of the reporter gene and 10 ,ug of pSV2neo. Following transfection, cells were subcultured and subjected to selection in growth medium containing 1 mg of G418 (40% active; GIBCO) per ml. After 2 weeks, the number of G418-resistant colonies was recorded and pooled cell lines were generated.
CAT assays. Chloramphenicol acetyltransferase (CAT) assays were performed as previously described (1, 51) . All assay mixtures contained the same amount of cellular protein. All radioactive species were quantified with an AMBIS Radioanalytic Imaging System, and CAT activity was expressed as percent conversion of the [14C]chloramphenicol substrate into all acetylated products.
EMSAs. Nuclear extracts were prepared as previously described (11 Purification of CTF/NF-1 and potato acid phosphatase (PAP) assay. Nuclear extracts were prepared from 20 confluent dishes (150-mm diameter) containing 2 x 108 to 5 x 108 cells. One milligram of nuclear extract protein was applied to a Mono Q-Sepharose column (1-ml bed volume) equilibrated in buffer D (11) containing 0.1 M KCl. The column was washed with 10 ml of equilibration buffer, and bound protein was eluted with a 0.6 M KCl step gradient and assayed for CTF/NF-1 by the EMSA. Fractions containing CTF/NF-1 were pooled, dialyzed against buffer Z (23, 25) containing 0.1 M KCl, and incubated with 50 ,ug of poly(dIdC) on ice for 10 min. The sample was applied in succession to two DNA affinity resins (1.5-ml bed volume) that were equilibrated in buffer Z containing 0.1 M KCl. The columns were washed with 10 to 15 ml of equilibration buffer, bound protein was eluted with a 0.6 M KCl step gradient, and fractions were examined for CTF/NF-1 by the EMSA. Fractions that contained CTF/NF-1 were pooled, dialyzed against buffer D, and frozen in liquid nitrogen. Affinity resins (Sepharose CL-4B) were prepared as previously described (23, 25) , using the double-stranded oligonucleotides GATC CTIT'l'GGAATCTATCCAAGTGGATC and GGGCT'lTT GGCTI7GAAGCCAAAAGCCC, which contain high-affinity CTF/NF-1 sites.
Affinity-purified CTF/NF-1 was combined with 5 ,ug of carbonic anhydrase (as carrier) and precipitated with icecold 10% trichloroacetic acid. Samples were washed with acetone, dried, dissolved in loading buffer lacking reducing reagents, and analyzed on SDS-10% polyacrylamide gels. Proteins were detected by silver staining.
Affinity-purified CTF/NF-1 was treated with increasing amounts of PAP (Sigma) in 0.1 M 2[N-morpholino]ethane sulfonic acid (MES; pH 6.0) at room temperature. Where indicated, 4 mM NaMoO4 or 0.5 M NaPO4 was included in the reaction mixture. The reaction was stopped by the addition of 4 mM MoO4 and analyzed by the EMSA using the 32P-adenovirus oligonucleotide.
[3H]thymidine incorporation. Cells were seeded into microscope slide culture chambers and grown to confluence. To induce quiescence, cultures were maintained at confluence for 3 days without a change of medium. At [3H]thymidine (5 ,uCi/ml) was added. Half of the cultures either received no treatment or were treated with 30% fetal calf serum. After 24 h, cultures were washed twice with phosphate-buffered saline, fixed in methanol-acetic acid (1: 1), and processed for autoradiography.
RESULTS
Normal and Myc-overexpressing 3T3-L1 cells contain dif- and, like CTF/NF-1, belongs to a larger family of CCAATbox-binding proteins (9) . Using a biochemical and genetic approach, we examined whether the properties of these D1 2 3 transcription factors were altered in 3T3-L1 cells that overexpress Myc. The results of EMSAs using nuclear extracts from normal * CBF 3T3-L1 cells and from 3T3-L1 cell lines that stably express a transfected c-myc or N-myc gene are shown in Fig. 1A . The c-Myc cell line has been previously described (14, 51) ; the N-Myc cell line expresses the N-myc mRNA at a level equal to that of the neuroblastoma line IMR-32 (16), which contains 15 to 20 copies of an amplified N-myc gene (46) . For the CTF/NF-1 DNA-binding assay, DNAs that contained the CTF/NF-1 site from the adenovirus origin of DNA replication and from the promoters of the mouse pro-a2(I) collagen, MMTV, and human c-myc genes were used as probes (Fig.  F_   1B sults indicate that the DNA-binding activity detected was specific and due to CTF/NF-1.
To obtain additional evidence that the complexes detected by the EMSA were due to binding of CTF/NF-1, we performed methylation interference footprinting using DNA that contained the adenovirus CTF/NF-1 site (Fig. 1C) 1B ) and were previously shown to be important for binding of affinity-purified human CTF/NF-1 to the adenovirus CTF/ NF-1 site (43). These results support our conclusion that the complexes detected by the EMSA are due to binding of CTF/NF-1.
In contrast to the results obtained for CTF/NF-1, we observed no difference in the DNA-binding activity of CBF when we compared extracts from normal and Myc-overexpressing cells (Fig. 1D) . DNA-binding assays for other transcription factors such as Spl and OTF-1 gave similar results (40, 50) . Thus, the differences observed for CTF/ NF-1 are specific and not due to differences in nuclear extract preparation.
Biochemical characterization of the various CTF/NF-1 forms. The various CTF/NF-1 forms detected in 3T3-L1 cells could arise by several different mechanisms. For instance, they might represent the products of distinct CTF/NF-1 genes, different products of the same gene that were generated by alternative RNA splicing or posttranslational modification, or different homo-or hetero-oligomeric forms of the CTF/NF-1 protein. To distinguish among these possibilities, we characterized the CTF/NF-1 forms by a variety of physical techniques in conjunction with the EMSA. Sedimentation velocity centrifugation on glycerol gradients showed that CTF/NF-1 forms I, II, and III in Myc-overexpressing cells (Fig. 2) and the sole CTF/NF-1 form in normal cells (not shown) sedimented together, indicating that they do not represent different degrees of oligomerization (e.g., monomer versus dimer) of the CTF/NF-1 protein. Although the CTF/NF-1 sedimentation profile was reproducibly broad, the peak (fraction 13) of each CTF/NF-1 form sedimented at 7S, which corresponds to a native molecular size of 122 kDa (assuming that all forms are globular). This value agrees well with the native molecular size of affinity-purified human CTF/NF-1 (120 kDa [32] ) and further supports our conclusion that the complexes detected by the EMSA are due to binding of CTF/NF-1. Given that affinity-purified human (23) and mouse (16) CTF/NF-1 migrate as a heterogeneous group of proteins on SDS-polyacrylamide gels ranging in size from 52 to 66 kDa, we believe that all of the CTF/NF-1 forms detected by the EMSA are either homo-or heterodimers. A fourth complex that sedimented at 4.2S (65 kDa; peak fraction 8) was occasionally detected in the gradients and may represent CTF/NF-1 monomers.
Addition of several different c-Myc-specific antibodies to the DNA-binding reaction did not affect the mobility or abundance of any of the CTF/NF-1 complexes in the EMSA (16) . We have no evidence that c-Myc is present in any of the CTF/NF-1 DNA-binding complexes.
Fractionation of nuclear extracts by ion-exchange chromatography demonstrated that the various CTF/NF-1 forms differed in charge density (Fig. 3) . The sole CTF/NF-1 form in normal 3T3-L1 cells and CT'/NF-1 form I in Mycoverexpressing cells coeluted from Mono Q-Sepharose at 0.29 M NaCl, raising the possibility that they represent the same CTF/NF-1 species. However, these CTF/NF-1 forms could be resolved in nondenaturing gels (clearly seen in Fig.  4B ) and on Mono-S Sepharose and heparin agarose (50) Nuclear extracts were fractionated on four different ionexchange resins (Mono-Q, Mono-S, heparin agarose, and phosphocellulose), and in every case, the DNA-binding activity of each CTF/NF-1 form never required more than one column fraction (50) . We have no evidence that any of the CTF/NF-1 forms are composed of heterologous subunits. This property distinguishes them from other CAATbox-binding proteins (9), including CBF (19, 37) , which binds to the CAAT box in the pro-a2(I) collagen promoter.
Interconversion of CTF/NF-1 forms by treatment with PAP. Because the various CTF/NF-1 forms differed in charge density, we investigated the possibility that they represented different phosphorylated forms of the CTF/NF-1 protein. CTF/NF-1 was purified from normal and Myc-overexpressing 3T3-L1 cells by Mono Q-Sepharose chromatography followed by successive passes over two different DNA affinity resins. Analysis of the affinity-purified material by SDS-polyacrylamide gel electrophoresis (nonreducing conditions) demonstrated that it consisted of a major diffuse protein band of 55 kDa and less abundant proteins ranging in size from 60 to 64 kDa (16) . These results agree well with those observed for affinity-purified human CTF/NF-1, which consists of a heterogeneous group of proteins ranging in sizes from 52 to 66 kDa (23) . Incubation of the affinitypurified material from Myc-overexpressing cells with PAP resulted in a marked decrease in the DNA-binding activity of all three CTF/NF-1 forms and a concomitant increase in the DNA-binding activity of a faster-migrating form ( Fig. 4A; compare lane 2 with lanes 4 to 8 and lanes 14 to 18). The major product of the PAP reaction and CTF/NF-1 form I are distinct because they can be cleanly resolved in nondenaturing gels ( Fig. 4B; compare lanes 3 and 4) . Over all concentrations of PAP except for the highest, the amount of increase in the DNA-binding activity of the new CTF/NF-1 form was equal to the combined loss of that of forms I, II, and III (Fig. 4A) , which is expected for a precursor-product relationship. The observed interconversion was inhibited by molybdate (lanes 9 to 13) and phosphate (not shown), two inhibitors of PAP, indicating that the reaction was catalyzed by PAP and not by a contaminating enzymatic activity. These results suggest that all of the CTF/NF-1 forms in Myc-overexpressing 3T3-L1 cells are phosphorylated. On the basis of relative charge density (Fig. 3) , form III may represent a higher phosphorylation state of the CTF/NF-1 protein than does form II, which may represent a higher phosphorylation state than does form I.
By contrast, the sole CTF/NF-1 form in normal 3T3-L1 cells was not significantly affected by PAP treatment (Fig.  4B, lanes 1 and 2) . Moreover, its mobility in nondenaturing gels was identical to that of the major product of the phosphatase reaction from Myc-overexpressing cells (compare lanes 1 and 3) but distinct from that of CTF/NF-1 form I (compare lanes 1 and 4) (48), and mouse pro-a2(I) collagen gene (37, 44) promoters and that glucocorticoid induction of the MMTV promoter, but not the basal activity, requires CTF/NF-1 binding. Cell lines that stably express the CAT gene driven by these CTF/NF-1-dependent promoters were established by cotransfection with pSV2neo. CAT plasmids that contain mutations in the sole CTF/NF-1 site of the collagen promoter and in all four CTF/NF-1 sites of the MoMuLV promoter were also used in this analysis. These mutations were previously shown to abolish CTF/NF-1 binding (44, 48) . Cells were also transfected with a pAlOcat-based plasmid that contained either a single high-affinity (TTGGCATCTAGCCAA [43] ) or mutant (TACCAATCTATGGTT) C2TF/NF-1 site positioned upstream of the simian virus 40 (SV40) early promoter. Cell lines that express the CAT gene driven by promoters that naturally lack a CTF/NF-1 site were generated as controls. Following selection in G418, pooled cell lines that contained on average 200 G418-resistant colonies were generated for each plasmid.
CAT expression was quantified in both quiescent and actively growing cell cultures. Representative CAT assays are shown in Fig. 6A , and the results are displayed graphically in Fig. 6B (quiescent cultures) and C (actively growing cultures).
In quiescent cell cultures (Fig. 6B) , each promoter that contained a functional CTF/NF-1 binding site was suppressed in cells overexpressing c-Myc. The SV40 promoter that contained a single high-affinity CTF/NF-1 site was on average eightfold less active, and the MoMuLV promoter, which contained four medium-affinity sites, was three-to fourfold less active in Myc-overexpressing cells than in normal cells. This difference in CAT expression was not due to differences in the average plasmid gene copy number per cell (16) . By contrast, mutant forms of these promoters that cannot bind CTF/NF-1 were equally active in both cell types. Thus, the differential promoter activity observed between normal and Myc-overexpressing cells requires
.__ .__ _. In contrast to the CGT/NF-1-dependent promoters, two promoters (human ,-actin and human argininosuccinate synthetase gene promoters) that naturally lack a CTE/NF-1 binding site showed no differential activity between normal and Myc-overexpressing cells (Fig. 6B) . Thus, overexpression of c-Myc does not globally suppress the promoter activity of transfected genes. Taken together, these results demonstrate that the activity of CTE/NF-1-dependent promoters is specifically suppressed in 3T3-L1 cells that overexpress c-Myc and that for the SV40, MoMuLV, and collagen promoters, this effect requires CTF/NF-1 binding.
The activities of these promoters were also examined in actively growing cell cultures. In sharp contrast to the activity observed with quiescent cultures, the CT'/NF-1-dependent promoters did not show differential activity between normal and Myc-overexpressing cells (Fig. 6C) .
Comparison of CIF/NF-1 in quiescent and actively growing cells. Because the CGT/NF-i-dependent promoters did not show differential activity between actively growing cultures of normal and Myc-overexpressing cells, we examined whether the same CTE/NF-1 forms were being expressed under these growth conditions. The EMSA detected four CTF/NF-1 complexes in actively growing cultures of 3T3-L1 cells (Fig. 7, lane 3) , which differs dramatically from the results for quiescent cultures (lane 2). Three of these complexes comigrated with CGT/NF-1 forms I, II, and III present in quiescent cultures of Myc-overexpressing cells (compare lanes 3 and 4) . Actively growing cultures of Myc-transformed cells also expressed these same four forms of CTE/NF-1 (compare lanes 3 and 5). These results provide an explanation for the observation that CGF/NF-1-dependent promoter activity is equal in normal and Myc-overexpressing cells under these growth conditions.
Because quiescent cultures of Myc-overexpressing cells expressed forms of GTE/NF-1 similar to those expressed by actively growing 3T3-L1 cells, it was possible that our method of inducing quiescence was ineffective and that a significant fraction of cells in the presumably quiescent cultures were still in active growth. To address this possibility, we monitored the incorporation of [3H]thymidine into DNA following induction of quiescence. Density-arrested cultures of Myc-overexpressing cells showed no evidence of DNA synthesis (Fig. 8C) , and cells (>95%) could be induced to enter S phase by treatment with 30% serum (Fig. 8D) . Similar results were obtained with normal 3T3-L1 cells (Fig.  8A and B (4) . Two findings of this study support the notion that the pleiotropic effect of Myc is mediated, in part, through transcription factor CITF/NF-1. First, stable expression of Myc (c-Myc and N-Myc) alters the biochemical forms of CTF/NF-1 that are expressed in 3T3-L1 cells. Five lines of evidence support our conclusion that the complexes detected by the EMSA contain CTF/NF-1. An oligonucleotide that binds to affinity-purified human CTF/NF-1 with high affinity is a better competitor in the EMSA than is an oligonucleotide that binds CTF/NF-1 less avidly. The native molecular weight of the proteins detected by the EMSA agrees well with that of affinity-purified human CTF/NF-1. The proteins detected by the EMSA have a DNA-binding affinity that is comparable to that of affinity-purified CTF/ NF-1 from other species, and they have the same base (G) requirements for binding to the adenovirus CTF/NF-1 site. Finally, the molecular sizes of affinity-purified CITF/NF-1 from 3T3-L1 cells (55 to 64 kDa) agree well with those of the affinity-purified human protein (52 to 66 kDa). Second, overexpression of Myc suppresses the activity of CT7F/NF-1-dependent promoters in vivo, an effect that requires CTF/ NF-1 binding. This conclusion is supported by four observations. Four CTF/NF-1-dependent promoters had less activity in quiescent cultures of Myc-overexpressing cells than in normal cells. In at least three cases, mutant forms of these promoters that cannot bind CTF/NF-1 showed no differential activity, demonstrating that this effect requires CTF/NF-1 binding. Actively growing 3T3-L1 cells, which express high amounts of c-Myc and contain similar CTF/ NF-1 forms found in quiescent Myc-overexpressing cells, showed a similar reduction in CTF/NF-1-dependent promoter activity relative to quiescent 3T3-L1 cells. Promoters that naturally lack a CTF/NF-1 site showed no differential activity between normal and Myc-overexpressing cells. Together, our results suggest that Myc may regulate (albeit indirectly) the biochemical activity of CTF/NF-1 in vivo.
The multiple CTF/NF-1 forms present in Myc-overexpressing cells and those in actively growing 3T3-L1 cells are converted into that found in quiescent '3T3-L1 cells by treatment with PAP ( Fig. 4) (Fig. 4B and 7) ; the various CTF/NF-1 forms cosediment in glycerol gradients; the observed gel shift patterns are observed in cell lines that overexpress either c-Myc or N-Myc; affinity-purified CTF/NF-1 produces the same gel shift pattern as do crude nuclear extracts. It is possible that a specific domain of CTF/NF-1 is phosphorylated during active growth or following Myc transformation. Confirmation of this possibility will require mapping and quantification of the phosphate moieties in the various purified CTF/NF-1 forms. Assuming that Myc functions as a transcriptional activator in vivo, Myc may activate a gene that codes for a CTF/NF-1 kinase.
Many of the known transcription factors are phosphoproteins. In several cases, a phosphorylation-dephosphorylation mechanism is used to regulate their activity during the cell cycle and following oncogenic transformation (20) . Most transcriptional activators are bimodular proteins composed of separate domains that function in DNA binding and transcriptional activation (35) . Phosphorylation of these domains can affect the DNA-binding affinity, the ability to stimulate transcription initiation, or both (20) . The results presented here demonstrate that the various CTF/NF-1 forms have the same DNA-binding affinity. Given that the relative abundance of the various CTF/NF-1 forms correlates with a different level of CTF/NF-1-dependent promoter activity in vivo, it is tempting to speculate that the biochemical activity of CTF/NF-1 is regulated in vivo by modification of its proline-rich transcriptional activation domain (32) . Future experiments will test these specific hypotheses.
CTF/NF-1 binds to the transcriptional control regions of a variety of cellular genes. Such genes code for proteins of the extracellular matrix [pro-al(I) and pro-a2(I) collagen] (44), human c-Myc (47), human c-Ha-Ras (23), and several abundant milk proteins (whey acidic protein and ao-lactalbumin) (34) . Expression of at least five of the aforementioned genes is suppressed in cells overexpressing c-Myc (2, 38, 39, 51) . The results described here suggest that the effect of Myc on collagen transcription is mediated through CTF/NF-1. The activity of the pro-a2(I) collagen promoter is suppressed twofold in 3T3-L1 cells that overexpress c-Myc. We believe that this effect is modest because the collagen CTF/NF-1 site differs significantly from the CTF/NF-1 consensus sequence (Fig. 1B) and binds to CT'F/NF-1 with a much lower affinity than do the other CT'F/NF-1 sites used in this study (16) . Several of these base differences are in positions of the recognition sequence that are important for CTF/NF-1 binding (Fig. 1C) (32, 43) . It is noteworthy that the SV40 promoter containing a single high-affinity CITF/NF-1 site showed eightfold differential activity between quiescent cultures of normal and Myc-overexpressing cells. The MoMuLV promoter, which contains four CTF/NF-1 sites of medium affinity (48) , also showed greater differential activity than did the collagen promoter. Thus, the magnitude of the differential effect seems to correlate with the CTF/NF-1 DNA-binding affinity. Our results lead us to believe that cellular genes that contain high-affinity CTF/NF-1 sites may be important physiological targets of Myc-suppressing activity. Such genes may include whey acid protein and a-lactalbumin, which are abundantly expressed in the mature breast epithelium. High transcription of whey acid protein and a-lactalbumin (and an endogenous MMTV provirus) in mouse breast epithelial cells requires CT7F/NF-1 binding (34) . Expression of these CTF/NF-1-dependent genes is suppressed in lactating mammary gland of transgenic mice overexpressing c-Myc (2). The ability to suppress CTF/NF-1-dependent promoters may be an important means by which Myc impairs differentiation, and promotes transformation, of breast epithelial cells in vivo.
